BASAS 2018 A Six-Sigma Approach in defining Programming Strategy of recurring deliverables JAGAN ACHI ASSOCIATE DIRECTOR, JAZZ PHARMACEUTICALS
BASAS 2018
A Six-Sigma Approach in defining Programming Strategy of recurring deliverables
JAGAN ACHI ASSOCIATE DIRECTOR, JAZZ PHARMACEUTICALS
Agenda
• Lean and Six Sigma concepts • Application of Lean Six Sigma to Drug Development recurring deliverable [DSUR]
Introduction
• Development of strategy for programming recurring deliverables/tasks is very common in drug development process.
• Statistical Programming groups in various companies use different techniques and methods to develop processes which would help there teams to achieve desirable outcomes.
• Selecting a right approach requires a careful planning and thorough understanding of the requirements and measuring, analyzing how the chosen approach is working and finally training the staff to implement it.
• In this presentation we will use how lean six sigma techniques [Define Measure Analyse Improve Control] can be used to define the right strategy with an example for generating Development Safety Update Reports [DSUR].
Lean • An improvement methodology based on customer centric definition of value and
providing that value in the most effective way possible, through a combination of the elimination of waste and a motivated and engaged workforce. Focus is on elimination of waste.
4
Over-production
Inventory Transportation
Over Processing
Waiting
Motion
Defects
Six Sigma Focus is on the quality improvement through reduction of variance
Define
• What is the Problem?
• What is the Scope?
• What key metric is important?
• Who are the stakeholders?
Measure
• What data is available?
• Is the data accurate?
• How should we stratify the data?
Analyze
• What are root cause of the problems?
• Have the root causes verifies?
• Where should we focus our efforts?
• What clues have been uncovered?
Improve
• Do we have the right solutions?
• How will we verify the solutions work?
• Have the solutions piloted?
• Have we reduced variation?
Control
• What do we recommend?
• Is there support for our suggestions?
• What is our plan to implement?
• Are results sustainable?
5
SIPOC Understanding the Process
• Provides the “before” picture so that you can compare “after” picture, hopefully demonstrating improvement Suppliers, Inputs, Process Steps, Outputs, Customers [SIPOC]
6
Supplier Input Process Output Customer
Define
CTQ – Critical to Quality
• Translate the broad requirements to specific, measurable and actionable performance requirements
• Start with the need and establish the quality requirements
7
Need Quality Requirement
Performance Requirement
Measure
Process Analysis
• Identify 7 wastes of Lean • Approach to problem solving by identifying which of your process steps are value
added and which are non value added
• TIMWOOD
8
Measure
Effort & Impact Analysis
9
Improve
Return on Investment
• Evaluate the efficiency of instrument • Compare the efficiency of a number of different investments • 1. Map the future state process. Review what is CTQ and ensure these measure
points are in your future state • 2. Identify the measurable improvements compared to the current state • 3. Calculate ROI
• Benefit- from future state • Current cost is from current state • Make all assumptions and calculations clear
10
Improve
Control Plan
• Sustain the gains identified from the project • Ensure Standardization of the future process such that the product always meet
customer requirements
11
Control
DSUR
• Development Safety Update Report [DSUR] is an annual report provided to the regulatory agencies
• Purpose is to regular Safety assessment of subjects in investigational drug to assess the benefit/risk before approval.
• Timing of DSUR is dependent on the sponsors first authorization to conduct a clinical trial in any country worldwide. Date of authorization will determine the annual reporting period.
Challenges
• Multiple regulatory agencies [FDA, EMEA] require different reports • Multiple times output generation • Cross functional coordination with PVG, Statistics, Programming and Data
Management • Multiple developmental phases for the drug • Vendor management to coordinate the data extract, SDTM transfers or ADaM
transfers
Define - Requirements
• ICH Guidelines: • http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/
09/WC500097061.pdf
• Biostatistics and Programming Requirements: • Outputs: Summary Reports and not datasets for Submission
• Datasets: Adverse Events, Demographics, Disposition, Exposure, Deaths • Data Mapping to standard controlled terminology • Programming of Summary tables and Listings • Derivation Rules:
• Treatment Emergent AE • Data Lock Dates • Exposure calculation, Subject Years • Maintaining Blinding
Shells
Shells
Shells
Shells
Approaches and Process analysis
DB SDTM ADaM DSUR
Output
DB SDTM + ADaM
DB ADaM+
DSUR Output
DSUR Output
Multiple
Define
Approaches and Process analysis
DB SDTM ADaM DSUR
Output Multiple
Measure
Approaches and Process analysis
DB SDTM + ADaM DSUR Output
Measure
Approaches and Process analysis
DB ADaM+ DSUR Output
Measure
Approaches and Process analysis
DB SDTM ADaM DSUR
Output
DB SDTM + ADaM
DB ADaM+
DSUR Output
DSUR Output
Multiple
Analyze
Effort & Impact Analysis
24
Improve
DB SDTM ADaM DSUR
Output
DB SDTM + ADaM
DB ADaM+
DSUR Output
DSUR Output
Multiple
Control Plan
Identify the best approach based on the principles and document a as Standard Operating Procedures or Work Process Documents. Train the team members on the new process and manage the change within the organization.
Summary and Discussion
• Lean six sigma principles can be applied to any process improvement • Applying the methodological technique would eliminate the seven types of wastes
and would help in gaining efficiencies within any organization
‘Its not the strongest that survive, nor he most intelligent, but one most responsive to change’ Charles Darwin